Properties (44)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_Qiagen_N.V.
|
| gptkbp:awards |
Various industry awards
|
| gptkbp:certifications |
gptkb:ISO_9001
gptkb:ISO_13485 CE Marking |
| gptkbp:collaborations |
Partnerships with pharmaceutical companies
|
| gptkbp:community |
Supports educational programs
Engages in corporate social responsibility initiatives Involved in environmental sustainability efforts Donates to health-related charities Participates in health awareness campaigns |
| gptkbp:employees |
Over 5,000
|
| gptkbp:focus |
Pharmaceutical development
Molecular diagnostics Agrigenomics Forensic testing Research and academic markets |
| gptkbp:founded |
1986
|
| gptkbp:founder |
gptkb:Joachim_Schneider
|
| gptkbp:headCoach |
Global presence in over 25 countries
|
| gptkbp:headquarters |
gptkb:Hilden,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Qiagen Pharma Solutions
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:innovation |
Invests heavily in R&D
|
| gptkbp:market |
Global
|
| gptkbp:partnerships |
Collaboration with various research institutions
|
| gptkbp:products |
DNA extraction kits
RNA extraction kits PCR_reagents |
| gptkbp:research |
Contributes to personalized medicine
Offers solutions for infectious disease research Provides tools for cancer research Supports academic research projects |
| gptkbp:revenue |
Approximately $1 billion
|
| gptkbp:services |
Bioinformatics
Clinical research services Sample and assay technologies |
| gptkbp:subsidiary |
gptkb:Qiagen_N.V.
|
| gptkbp:technology |
Bioinformatics software
Next-generation sequencing Real-time PCR Microarray_technology |
| gptkbp:website |
www.qiagen.com
|